Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3430898 Target Snapshot

DNA gyrase subunit A/DNA gyrase subunit B · PROTEIN COMPLEX · Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)

397Compounds
38Assays
4Approved Drugs
414.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P9WG45. Use UniProt P9WG45 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P9WG45 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats DNA gyrase subunit A/DNA gyrase subunit B as ChEMBL target CHEMBL3430898, mapped to UniProt P9WG45. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
DNA gyrase subunit A/DNA gyrase subunit B
PROTEIN COMPLEX · Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
As of 2026-09-14
ChEMBL target ID
CHEMBL3430898
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P9WG45
DNA gyrase subunit B
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether DNA gyrase subunit A/DNA gyrase subunit B is the right protein anchor across sources, using UniProt P9WG45 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDNA gyrase subunit B
UniProt AccessionP9WG45
Component TypeProtein
Sequence Length675 aa

DNA gyrase subunit B

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as DNA gyrase subunit A/DNA gyrase subunit B, mapped to UniProt P9WG45. ChEMBL maps the protein component as DNA gyrase subunit B. Sequence length is 675 aa.

Mapped IDP9WG45
Review nameDNA gyrase subunit A/DNA gyrase subunit B
OrganismMycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
Clinical Profile

Clinical Phase Distribution

4
Approved
1
Phase III
Assay Mix

Activity Type Distribution

IC50414.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5612596 8.39 IC50 4.1 Preclinical
CHEMBL4238919 8.3 IC50 5.0 Preclinical
CHEMBL4250651 8.0 IC50 10.0 Preclinical
CHEMBL36506 7.82 IC50 15.0 Approved
CHEMBL3114205 7.52 IC50 30.0 Preclinical
CHEMBL3114216 7.29 IC50 51.0 Preclinical
CHEMBL3286436 7.19 IC50 65.0 Preclinical
CHEMBL3608760 6.98 IC50 104.0 Preclinical
CHEMBL3290337 6.96 IC50 110.0 Preclinical
CHEMBL3608758 6.96 IC50 110.0 Preclinical
Distribution

pChEMBL Value Distribution

101
5.0
28
5.5
32
6.0
13
6.5
11
7.0
4
7.5
3
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

NOVOBIOCIN
CHEMBL36506
Approved 1964
Assay Landscape

Assay Landscape

38
Total Assays
329
Tested Compounds
1
Assay Types
Binding — 38 assays, 329 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 25 297 5.2
protein complex format 13 32 5.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine